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Objective: To determine the impact of prehabilitation on hospital length of stay, functional 
capacity, complications, and mortality after surgery in patients with hepatobiliary, colorectal, 
and upper gastrointestinal cancer. 
Background: “Prehabilitation” encompasses exercise, nutrition, and psychosocial 
interventions to optimise health before surgery. The benefits of prehabilitation are ill-defined.  
Methods: Medline, Embase and Cochrane Databases were searched systematically for the 
terms “prehabilitation AND exercise”, “perioperative care AND cancer surgery”, and “colorectal 
AND hepatobiliary AND hepatopancreatobiliary AND oesophagogastric AND recovery AND 
outcomes”. Primary outcomes analysed were hospital length of stay, functional capacity, 
significant post-operative complications (Clavien Dindo ≥ III), and mortality. A meta-analysis 
was conducted on the effect of all-modality prehabilitation for patients with colorectal, 
hepatopancreatobiliary and upper gastrointestinal cancer surgery using the raw mean 
difference, risk difference, and a random-effects model. 
Results:  337 original titles were identified. 15 studies (randomised controlled trials; n = 9 and 
uncontrolled trials; n = 6) were included in the meta-analysis. Prehabilitation reduced hospital 
length of stay by 1.78 days versus standard care (95% CI:  -3.36, -0.20, P <0.05). There was 
no significant difference in functional capacity with prehabilitation determined using the six-
minute walk test (P = 0.816) and no significant reduction in post-operative complications (P = 
0.378) or mortality rates (P = 0.114). 
Conclusion: Prehabilitation was associated with reduced hospital length of stay but had no 
effect on functional capacity, post-operative complications, or mortality rates. Thus, 
prehabilitation should be recommended to accelerate recovery from cancer surgery, 




Recently, the focus around recovery following cancer surgery has shifted towards better 
preparation of patients for surgery1,2. While enhanced recovery after surgery is now standard 
post-operative care3, several studies have suggested additional benefits from increasing the 
cardiorespiratory fitness of patients before surgery2,4,5. “Prehabilitation” has gained popularity 
as an umbrella term to describe physical exercise, nutritional, and psychosocial interventions 
to optimise physical and mental health prior to major surgery 6.     
Recent systematic reviews have demonstrated that prehabilitation can reduce hospital 
length of stay in major non-cancer surgery (e.g. bariatric surgery) 7,8 but the benefit in 
hepatobiliary, colorectal, and upper gastrointestinal cancer is largely unknown. These cancer 
patients are a unique population characterised by different clinical outcomes, length of stays, 
and surgical procedures. Indeed, these cancer patients may benefit significantly from nutrition 
and exercise programmes, as patients often present with weight loss (indicating 
malnourishment), and tend to be less physiologically fit than other cancer groups9. 
Collectively, this results in a hospital length of stay after oesophagectomy of 7-14 days10, for 
example, whereas this is only 3.1 days after bariatric surgery 11. Knowing whether 
prehabilitation reduces hospital length of stay or complication rates in cancer patients 
specifically is important because this can influence adjuvant therapy. Recent work has 
suggested that colorectal cancer patients in particular are highly resistant to the benefits of 
exercise12 and thus, examining the impact of exercise and nutrition on this population is 
valuable.  
The two most frequently studied forms of prehabilitation are exercise and nutritional 
interventions. It has been shown that preoperative exercise increases fitness before operation 
and several studies have reported improvements in cardiopulmonary exercise test variables 
(V̇O2max & anaerobic threshold) and functional capacity3,24 after supervised and unsupervised 
pre-operative exercise programmes4,5,13. Several studies have reported that improved pre-
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operative fitness is associated with accelerated post-operative recovery following major 
abdominal surgery14–18. Benefits from prehabilitation include reduced hospital length of stay 
1,19 and a reduced incidence of post-operative complications20–22. While no studies have 
reported exercise prehabilitation has a deleterious effect on post-operative outcomes, some 
studies have found no effect when prehabilitation is compared to standard care 20,23. This may 
be a result of underpowered studies, “non-responder” effects to exercise 24, or that there is no 
clinically meaningful effect. Moreover, the response to prehabilitation is a complex 
phenomenon and whilst less fit patients are more likely to benefit most, prehabilitation does 
not guarantee good outcomes. Lastly, time to surgery is an independent factor that affects 
survival in cancer 25, and this is a major challenge to prehabilitation. Collectively, these data 
suggest exercise prehabilitation is capable of improving post-operative surgical outcomes, but 
the benefits to patients across studies and exercise-modalities remain to be determined.  
Whilst there is evidence that poor nutritional status is an independent predictor of post-
operative complications in colorectal cancer patients26–29, there are few studies that have 
studied the possible benefits of nutritional prehabilitation for cancer surgery. It has been shown 
that under-nourished or ‘at risk’ patients are likely  to have more post-operative complications 
26, although the benefits are not always clear. Studies providing carbohydrate and protein 
supplementation in eucaloric populations pre-surgery have shown little benefit 30,31. However, 
studies concerning protein provision have shown promising results including reduced hospital 
length of stay, lower rates of post-operative complications, and reduced readmission rates, 
regardless of baseline nutritional status 32. The net benefit of nutritional interventions before 
major cancer surgery remains to be determined.  
Psychosocial interventions are often implemented as part of wider multimodal 
prehabilitation and aim to reduce stress and anxiety through education and counselling 
2,23,33,34. Further, studies have shown psychosocial interventions can augment improvements 
following exercise 35 or nutritional 36 interventions. Studies examining psychosocial-
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prehabilitation have, however, either not reported psychology-specific outcomes 2 or showed 
no significant improvement in anxiety and depression scores23,33.  
Despite potential advantages of prehabilitation to improve patient outcomes after 
cancer surgery, the benefits relating to specific cancer types are less clear. Concerning 
patients undergoing surgery for colorectal, hepatopancreatobiliary, and oesophagogastric 
cancer, there has been no meta-analysis to provide pooled analysis of the evidence from 
published studies to date. Therefore, the aim of this systematic review and meta-analysis was 
to determine the impact of prehabilitation on hospital length of stay, functional capacity 
(measured by the six-minute walk test [6MWT]), post-operative complications, and mortality 





This systematic review and meta-analysis was conducted in accordance with PRISMA 
guidelines 37. JL and LH independently conducted the eligibility assessment in an unblinded 
and standardised manner. Where there was disagreement, CG served as the final adjudicator. 
Once each database search was completed and manuscripts were sourced, all studies were 
downloaded into a single reference list with duplicates removed. Eligibility was assessed 
based on the criteria below. For eight of these studies, authors were contacted for 
supplementary data.  
 
Literature search and study selection 
A systematic literature search was conducted in Medline, Embase, and Cochrane databases 
with no start date but we included papers published to December 18th, 2019. The search was 
performed within all fields and terms used were “prehabilitation” AND “peri-operative care” OR 
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“perioperative care” AND “major surgery” OR, “colorectal” OR “hepatobiliary” OR 
“oesophagogastric” AND “outcomes” AND “complications”.  
Studies that met the following criteria were included in this meta-analysis: (1) published 
as a full-text manuscript; (2) not a review or protocol manuscript; (3) studies involving patients 
undergoing elective colorectal, hepatopancreatobiliary, oesophagogastric cancer surgery, and   
colorectal resections for benign disease. All included studies were required to employ an 
intervention design and include at least one aspect of prehabilitation. Specifically, this included 
(i) an exercise programme for at least one week to include; aerobic, resistance, and concurrent 
exercise at all exercise intensities. Inspiratory muscle training (IMT) studies were also included 
in this category, as evidence suggests they can increase functional capacity 38 or (ii) nutritional 
supplementation. Three studies included in the meta-analysis provided psychosocial support 
including information and/or counselling in addition to the exercise and/or nutrition 
intervention. Additionally, descriptive data (e.g. sample size, mean, and standard deviation) 
must have been reported. Where these were not reported, details were requested from 
authors. The aim was to investigate the impact of prehabilitation on hospital length of stay, 
functional capacity (measured by the six-minute walk test [6MWT]), post-operative 
complications, and mortality rates in hepatobiliary, colorectal, and upper gastrointestinal 
cancer. Where studies measured multiple outcomes, they were treated as separate data 
points. Due to the small number of studies, subgroup analysis was not possible for the three 
cancer types or different exercise modalities.   
Full text articles and supplementary data were reviewed to assess methodological 
quality of each study, using the PEDro scale, which quantifies the methodological quality39.  
Before analysis, studies were further categorised into the primary and secondary outcomes 
that were recorded. To assess publication bias, funnel plots for each outcome variable were 





From each eligible article, data were extracted for hospital length of stay, functional capacity, 
post-operative complications, and mortality rates by prehabilitation intervention type. 
Interventions were grouped into three types (i) Multimodal prehabilitation: exercise, which 
included both nutrition and psychosocial support, (ii) bimodal prehabilitation: exercise and 
nutrition or psychosocial support, and (iii) unimodal prehabilitation: exercise or nutrition alone. 
Exercise interventions included were; aerobic, resistance, and concurrent exercise (combined 
aerobic/resistance exercise) at all exercise intensities. Regimes involving supervision by a 
kinesiologist or physiotherapist, and unsupervised home-based exercise regimes were 
included. Exercise intervention duration ranged from 1 week to 4 weeks and all interventions 
were within the current NHS surgery targets for cancer surgery41. It was our intention to 
summarise participant characteristics to determine if baseline fitness, clinical status, or 
nutrition status influenced outcome variables. However, due to absence of details in participant 
descriptions within the original investigations, this was not possible. 
Where data were missing, authors were contacted via email to provide supplementary 
information. A total of eight requests were sent and a 2-week period given for responses. A 
further reminder email was sent after this period and a further week given to respond. Three 
responses were received. Data were imported into a software package designed to perform 
meta-analyses (The jamovi project (2020), jamovi (Version 1.2) [Computer Software]. 
Retrieved from https://www.jamovi.org). Figures were prepared in jamovi and GIMP (GIMP 
2.8.4, retrieved from https://gimp.org).  
  
 
Data quality assessment and statistical analysis 
In this meta-analysis the cumulative effect of bias can lead to overstating or understating 
treatment effects. The Physiotherapy Evidence Database (PEDro) scale was used to assess 
the risk of bias of included studies 39. Supplemental Table 1 shows how PEDro scores were 
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assigned based on itemised criteria. Random-effects meta-analyses were conducted, and 
comparisons were made between standard care and prehabilitation. For length of stay and 
functional capacity, raw difference in means was calculated, and for post-operative 
complications and mortality rates, the risk difference. Functional capacity was determined 
using 6MWT, as previously validated in this population42. Distance completed in meters was 
reported in all studies, and therefore we report the raw mean difference between standard 
care and prehabilitation. Whilst functional capacity comprises a range of functional activities, 
the six-minute walking distance has been studied and considered a valid and reliable 
measure42.   
Hospital length of stay was reported in days from the date of operation to the date of discharge.  
The outcome measure for surgical complications was the number of Clavien-Dindo (CD) ≥ III 
complications reported22. Grade I & II were classified as minor complications and III & IV as 
major complications. These outcomes were selected as clinically meaningful endpoints in the 
majority (all studies reported at least 1 out of these 3 outcomes; length of stay, functional 
capacity, and complications) of published prehabilitation studies relevant to this review.  
Heterogeneity was quantified with the I2 statistic. An I2 value of 25% was interpreted as low, 
50% as moderate and 75% as high between-study heterogeneity. To determine if the length 
of prehabilitation was an important factor in determining patient outcomes, we completed 
linear regression analysis between the length of prehabilitation and hospital length of stay, 
functional capacity, post-operative complications, and mortality rates. Significance was set at 









After the initial database search, 337 publications were identified. Once duplicates were 
removed, 157 titles and abstracts were screened for inclusion (Fig. 1). After initial exclusions, 
50 studies were retrieved as a full text and assessed for eligibility. Of those, 35 were excluded 
leaving 15 eligible articles for the final quantitative analysis (Fig. 1).  
 
Study characteristics 
Of the 15 studies included, 9 were randomised controlled trials and 6 were uncontrolled trials 
(Supplemental Table 2). Three studies examined the effect of multimodal prehabilitation, 
seven studies examined bimodal prehabilitation, and five studies examined unimodal 
prehabilitation. For grouping studies together, it was important to assess the type, duration 
and intensity of exercise across studies using exercise as prehabilitation. Although type, 
intensity and frequency of exercise varied between studies, most reported achieving ≥ 50% 
maximum heart rate. In one study where two exercise interventions (low intensity vs moderate 
intensity/strength training)15 were compared, the low intensity unsupervised exercise 
intervention was treated as the ‘standard’. The meta-analysis was run with and without this 
study and no difference in overall outcome was observed. In studies where nutrition was 
utilised, nutritional optimisation was homogenous and standardised amongst studies at 1.2-
1.5 g protein/kg body mass.
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Effect of prehabilitation on hospital length of stay  
Three studies investigated hospital length of stay and observed a significant reduction of 1.78 
days (95 % CI:0.2, 3.36, P <0.05), Fig. 2. There was low heterogeneity (I2 <0.001%) amongst 
studies reporting this outcome. The small number of studies limits assessment of plot 
symmetry and bias. Linear regression analysis showed there was no significant relationship 
between length of prehabilitation and hospital length of stay (R2 = 0.99, P >0.05).  
 
Effect of prehabilitation on functional capacity  
Seven studies examined the impact of prehabilitation on functional capacity, measured by the 
6MWT. There was no significant difference in functional capacity with prehabilitation (+2.82 
m, 95 % CI: -20.92, 26.56, P = 0.816), Fig. 3. There was a moderate level of heterogeneity (I2 
= 31.19%). The small number of studies limits an assessment of symmetry and bias. Linear 
regression analysis showed there was no significant relationship between length of 
prehabilitation and change in functional capacity (R2 = 0.24, P >0.05).  
 
Effect of prehabilitation on post-operative complications  
We examined the effect of prehabilitation on grade III & IV Clavien-Dindo post-operative 
complications as a lower rate of surgical complications might explain reduced hospital length 
of stay. The overall risk difference in post-operative complications was -0.02 (95 % CI = -0.07, 
0.03; P = 0.378; Fig. 4), indicating that there was no significant reduction in the risk of clinically 
important post-operative complications following prehabilitation. There was a moderate level 
of heterogeneity (I2 = 39.73%). The funnel plot demonstrates some symmetry which suggests 
low level of publication bias. Linear regression analysis showed there was no significant 
relationship between length of prehabilitation and post-operative complication rates (R2 = 0.05, 





Effect of prehabilitation on mortality rates 
Mortality was reported in eight of fifteen studies, although two studies reported no deaths in 
the monitoring period and thus were excluded from the meta-analysis. The remaining six 
studies all recorded 30-day mortality, while one study additionally reported 90-day mortality. 
The overall risk difference in mortality rates was -0.09 (95% CI = -0.21, 0.02, P = 0.114, Fig 
5), indicating there was no significant effect of prehabilitation on mortality rates. There was a 
high level of heterogeneity (I2 = 98.95%). Linear regression analysis showed there was no 




Overall effect of all prehabilitation modalities 
The main finding from this meta-analysis was a statistically significant reduction in hospital 
length of stay with a mean reduction of 1.8 days with prehabilitation. The randomised 
controlled trial by Barberan-Garcia et al. employed a combination of high intensity training and 
psychosocial motivational coaching in a population undergoing curative colorectal, liver 
resections, and oesophagogastric resections33. This study was deemed high quality and 
registered eight on the PEDro scale. The largest uncontrolled trial of 627 patients (77% of 
which were colorectal resections) used a combination of aerobic/resistance training and 
protein supplementation43. The smallest uncontrolled trial comprising pancreatic and 
oesophagogastric resections employed a combination of incentive spirometry, moderate 
intensity exercise and protein supplementation20. These two studies achieved lower PEDro 
scores of three and four, respectively. From the data it was not possible to ascertain which 
aspect of prehabilitation had the largest influence on the reduced hospital length of stay. In 
most clinical settings this phenomenon is often multifactorial, however, the data from individual 
studies33,44 suggests reduced complication rates may explain the reduced hospital length of 
stay, although this was not confirmed in this meta-analysis. In their study of 
pancreaticoduodenectomies Kitahata et al. showed no difference in operation-specific 
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complications such as delayed gastric emptying or leak rates between prehabilitation and 
standard care. However, the prehabilitation group had a significantly reduced median hospital 
length of stay (16 vs. 24 days) due to lower pulmonary complications44.    
Of the fifteen studies, eight assessed functional capacity as measured by the 6MWT. 
There were four23,45–47 moderate to high quality studies (PEDro ≥ 7). There was some variation 
between the studies with respect to the distance at which the 6MWT was deemed clinically 
meaningful. For example, one study set a threshold distance of 20 metre walking distance 
improvement from baseline as clinically significant46, which was based on a prior study by 
Antonescu et al.48 estimating minimally clinically important differences in patients undergoing 
abdominal surgery. This was not specific to cancer surgery. Another study suggested that a 
distance improvement of at least 19 metres had to be reached49. This distance was thought to 
be clinically meaningful as it represented the measurement error in this patient cohort42. All 
four studies reported an improvement in walking distance in the prehabilitation group 
compared to standard care. However, this effect was sustained at 4 and 8 weeks post-
operatively in only two45,47 out of the four studies. This suggests that sustained improvements 
in functional capacity may relate to the type of surgery and the timing of measurements after 
prehabilitation (before/after surgery). Additionally, benchmarks for clinically relevant 
improvements may be different for different studies involving the same type of surgery. This 
presents a challenge in pooling functional capacity data.  
While some individual studies examined reported a statistically significant 
improvement in functional capacity, this was not replicated in our pooled analysis. The 
optimum type, duration, frequency, and intensity of exercise required to observe 
improvements in functional capacity within this patient cohort remains elusive. 
It is also unclear what the contribution of nutrition would be to the observed overall 
effects. A single study by Gillis et al. used unimodal prehabilitation with nutrition counselling 
and whey protein supplementation46.  In this study, although an improvement in the 6MWT 
was observed, it was not statistically significant. The variability in response of functional 
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capacity probably supports a tailored prehabilitation approach50 for different types of cancer 
surgery. Due to the variability in exercise types, frequency, and duration it was not possible to 
group cancer types together to arrive at a combined effect for functional capacity. This is 
pertinent in cases where physiological/biological differences may affect the response to 
prehabilitation strategies51,52 as well as the effect of neoadjuvant chemotherapy 53, long/short 
course chemoradiation 54, and pre-operative jaundice 55.    
Prehabilitation interventions spanned from as little as 1 week 44 to a maximum of 6 
weeks19. Interestingly, in this meta-analysis, there was no statistically significant relationships 
between the duration of prehabilitation and the improvement in patient outcomes. However, 
when examining hospital length of stay, there was a strong (although non-significant) 
correlation (R2 = 0.99) where shorter periods of prehabilitation promoted greater reductions in 
hospital length of stay 43. More studies using different lengths of prehabilitation are required to 
determine if this relationship is significant. Prehabilitation interventions are constrained by 
National Health Service cancer waiting targets (or equivalent) but encouragingly, the results 
from this study suggest as little as one week can benefit patient outcomes.  
 
 
Effect of prehabilitation in Hepato-Pancreato-Biliary (HPB) cancer surgery 
There was a total of 842 patients from six studies5,19,20,33,44,56 that used  different combinations 
of multimodal, bimodal, and unimodal prehabilitation. The published data suggests that 
prehabilitation in HPB cancer surgery results in reduced hospital length of stay, fewer post-
operative complications and preservation of gastric function, although these results have not 
been consistent between studies. Nakajima et al. compared a prehabilitation group (exercise 
and nutrition) with a matched historical cohort and showed significant reductions in hospital 
length of stay in the prehabilitation group19. In a similar study design involving the analysis of 
a retrospective control group compared to an exercise and nutrition prehabilitation group, a 
reduced hospital length of stay was not observed but there was a significant reduction in 
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Clavien Dindo ≥ III post-operative complications20. This finding was replicated in another study 
which randomised patients to standard care or high intensity exercise and motivational 
interviews as the prehabilitation intervention33. The authors reported a significant reduction in 
post-operative complications, possibly explained by an increase in aerobic capacity.  
In contrast Ausania et al. employed nutrition (liquid protein/carbohydrate and enzyme 
replacement) and exercise prehabilitation in a total cohort of 40 patients undergoing 
pancreaticoduodenectomy. There was no difference in post-operative complications 
(pancreatic leak) and hospital length of stay. However, a significant reduction in delayed 
gastric emptying was found in the prehabilitation group56. This finding may suggest that 
prehabilitation might improve underlying physiology57, however, it does not translate to 
reduced complication rates and length of stay with the number of patients studied. If 
prehabilitation does improve underlying physiology, the specifics and mechanisms remain to 
be determined. In a large retrospective series of 576 pancreaticoduodenectomies, Kitahata et 
al. reported a significant reduction in pulmonary complication rates and length of stay within a 
supervised exercise prehabilitation programme compared to standard care historical cohort44. 
However, there was no difference in the incidence of operation specific complications such as 
pancreatic/biliary leak rates and specifically delayed gastric emptying as observed by Ausania 
et al 56.  
Dunne at al.5 examined aerobic capacity using cardiopulmonary exercise testing data 
in patients undergoing colorectal liver metastases resections. A four-week exercise 
prehabilitation programme significantly improved maximal oxygen uptake and anaerobic 
threshold, and quality of life, compared to a control group5. Collectively, these data suggest 
that as little as four weeks of exercise prehabilitation can exert clinically significant benefits for 
patients.  
 
Effect of prehabilitation in colorectal cancer surgery 
Prehabilitation studies concerning colorectal cancer have had mixed results, whereby some 
studies reported reduced hospital length of stay or improvements in functional capacity, but 
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others have not. In the body of literature we reviewed, there appears to be no evidence for 
improvement in post-operative complications in colorectal cancer with prehabilitation. In 
particular, there was no difference in operation-specific colorectal complications such as 
anastomotic leak, ileus or wound infection58.   
A total of 1113 patients from nine studies2,13,15,23,33,34,43,46,47 employed prehabilitation 
modalities. Chia et al. focused on a group of frail patients undergoing colorectal resections 
and employed a multimodal prehabilitation programme. Authors reported a reduced length of 
stay, although there were no differences in complication rates and 30-day mortality34. 
Bousquet-Dion et al. assessed functional capacity and found that prehabilitation made no 
difference to this measure. However, patients deemed most likely to show improvements were 
the sedentary cohorts as defined by the Community Healthy Activity Model Programme for 
Seniors questionnaire23,59. In a larger study involving 484 colorectal resections, Janssen et al. 
showed significant reductions in peri-operative delirium but there was no difference in length 
of stay, complications and 30-day mortality43. In two separate studies46,47 involving unimodal 
and multimodal prehabilitation respectively, a significant improvement in functional capacity 
was reported with moderate and high intensity exercise, although these have also been 
observed in low intensity exercise15. These data suggest that there may be metabolic and 
physiological differences between patients that influence responses to prehabilitation 
interventions24,52. This raises a further question of how to select patients that might benefit the 




Effect of prehabilitation in upper gastrointestinal cancer surgery 
Prehabilitation for upper gastrointestinal cancer surgery has led to improvements in functional 
capacity and reductions in post-operative complications. Our analysis is based on a group of 
120 patients from three studies20,33,45. Minnella et al. studied 49 oesophagogastric resections 
and reported a significant improvement in functional capacity45. Mazzola et al. found a 
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reduction in post-operative complications (Clavien-Dindo ≥ III) in patients enrolled on a 
prehabilitation programme20. Although Barberan et al. 33 also reported similar significant 
reductions in serious post-operative complications, it was not possible to isolate outcomes for 
upper gastrointestinal surgery patients as the group was combined with both colorectal and 
HPB surgery in the study. Overall, there was no difference in hospital length of stay between 
the standard and prehabilitation groups.  
 
Strengths and limitations 
In this study we have been able to perform a comprehensive review of the impact of 
prehabilitation in HPB, colorectal, and upper-gastrointestinal surgery. By the use of PEDro 
scoring we have managed to assess quality of included studies. However, this study is not 
without limitations. The most pertinent limitation of this meta-analysis was the paucity of 
randomised controlled trials60. There were nine randomised controlled trials with a PEDro 
score ranging 5-8, which made evaluating the efficacy of prehabilitation challenging61. For the 
exercise interventions, there were not enough studies to allow pooling of low, moderate, and 
high intensity exercise subgroups. These details would allow the determination of the minimum 
amount, type, intensity, and frequency of aerobic/strength training to improve functional 
capacity or clinical outcomes. Likewise, although most nutrition interventions involved protein 
or carbohydrate supplementation, the variability in compliance likely rendered any additive or 
individual effect of nutrition inconclusive62.    
Another limitation of this literature in this field is the lack of detail in reporting. Few 
studies reported objective measures of exercise intensity and volume. Moreover, compliance, 
adherence, and attendance were not reported in the majority of investigations. Therefore, it is 
possible that the effect on hospital length of stay was the result of analysing patients most 
determined, and most able to complete the programme. Hospital length of stay may not have 
been improved in all participants, just those who completed the prehabilitation. Intention to 
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treat analysis and recording attendance and adherence would improve the rigour of reporting 
in future studies. 
While the authors of analysed studies made efforts to ensure homogeneity of patient 
characteristics and minimise bias through randomisation and matching comparative cohorts, 
it is possible that inherent/confounding differences in participant characteristics could have 
affected outcomes. For example, the individual motivation levels of participants to complete 
and adhere to interventions cannot be accounted for through randomisation. 
 
There were no studies that assessed the sole or combined effect of psychosocial 
optimisation and thus, further studies here are warranted. The studies that reported 
psychosocial intervention as part of a bimodal or multimodal prehabilitation programme 
provided no analysis or supplementary data to support its use. Due to the differences in the 
patient populations, interventions and outcome measurements we believe that the application 
of a random effects model meta-analysis was justified. A random-effects model also supports 
assigning a heavier weighting to the smaller studies that achieved a higher PEDro score. 
Lastly, the mortality data was associated with considerable heterogeneity, although we have 
used a random effects model to moderate the influence of this. Future studies should record 
mortality rates at standardised time-points to allow for comparison. 
 
Summary and conclusion 
Prehabilitation can effectively reduce hospital length of stay in hepatobiliary, colorectal, and 
upper gastrointestinal cancer surgery. There is a lack of randomised controlled trials in this 
population (n = 9), of which only three scored 8 or greater on the PEDro scale and two of the 
studies contained only 48 and 49 patients, respectively. Thus, there is a need for larger, high 
quality randomised controlled trials to expand the evidence base for adoption and 
implementation of prehabilitation programmes and provide statistical sensitivity for low 
 18 
incidence measures such as mortality. In particular, the type, duration, frequency, and intensity 
of exercise intervention needs to be standardised. Secondly, training variables appropriate for 
each cancer type require further examination. To improve quality and rigour of future 
investigations, measurement of discrete variables such as cardiopulmonary exercise test 
parameters63 pre- and post-prehabilitation may provide a standardised basis for analysing 
improvements in cardiorespiratory fitness, which would avoid the apparent variability in 
selection of a clinically meaningful benchmark for improvement in functional capacity. Future 
studies should focus on identifying patients who would benefit most from prehabilitation and 
the mechanistic underpinning of any improvement in clinical outcomes. Studies should closely 
monitor nutrition intake to determine if the response to exercise prehabilitation is dependent 
upon nutritional status. Lastly, mortality should be monitored for 12 months post-surgery to 




JEL was funded by East Lancashire Teaching Hospitals NHS Trust. The funder had no role in 
the study design, data collection, analysis or interpretation of the data. The authors declare 
no conflict of interest.  
 
REFERENCES 
1.  Souwer ETD, Bastiaannet E, de Bruijn S, et al. Comprehensive multidisciplinary care 
program for elderly colorectal cancer patients: “From prehabilitation to independence.” 
Eur J Surg Oncol. 2018;44:1894–1900. 
2.  Chen BP, Awasthi R, Sweet SN, et al. Four-week prehabilitation program is sufficient 
to modify exercise behaviors and improve preoperative functional walking capacity in 
patients with colorectal cancer. Support Care Cancer. 2017;25:33–40. 
3.  Pędziwiatr M, Mavrikis J, Witowski J, et al. Current status of enhanced recovery after 
 19 
surgery (ERAS) protocol in gastrointestinal surgery. Med Oncol.;35 . Epub ahead of 
print 2018. DOI: 10.1007/s12032-018-1153-0. 
4.  Huang GH, Ismail H, Murnane A, et al. Structured exercise program prior to major 
cancer surgery improves cardiopulmonary fitness: a retrospective cohort study. 
Support Care Cancer. 2016;24:2277–2285. 
5.  Dunne DFJ, Jack S, Jones RP, et al. Randomized clinical trial of prehabilitation before 
planned liver resection. Br J Surg. 2016;103:504–512. 
6.  Carli F, Gillis C, Scheede-Bergdahl C. Promoting a culture of prehabilitation for the 
surgical cancer patient. Acta Oncol (Madr). 2017;56:128–133. 
7.  Moran J, Guinan E, McCormick P, et al. The ability of prehabilitation to influence 
postoperative outcome after intra-abdominal operation: A systematic review and 
meta-analysis. Surgery. 2016;160:1189–1201. 
8.  Hughes MJ, Hackney RJ, Lamb PJ, et al. Prehabilitation Before Major Abdominal 
Surgery: A Systematic Review and Meta-analysis. World J Surg. 2019;43:1661–1668. 
9.  Keum N, Bao Y, Smith-Warner SA, et al. Association of Physical Activity by Type and 
Intensity With Digestive System Cancer Risk. JAMA Oncol. 2016;2:1146–53. 
10.  Ma L, Li J, Shao L, et al. Prolonged postoperative length of stay is associated with 
poor overall survival after an esophagectomy for esophageal cancer. J Thorac Dis. 
2015;7:2018–23. 
11.  Zhao Y, Encinosa W. Bariatric Surgery Utilization and Outcomes in 1998 and 2004: 
Statistical Brief #23. Agency for Healthcare Research and Quality (US) Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/21938831. 2006. Accessed September 3, 
2020. 
12.  Boereboom CL, Blackwell JEM, Williams JP, et al. Short‐term pre‐operative high‐
intensity interval training does not improve fitness of colorectal cancer patients. Scand 
 20 
J Med Sci Sports. 2019;29:1383–1391. 
13.  Kim DJ, Mayo NE, Carli F, et al. Responsive measures to prehabilitation in patients 
undergoing bowel resection surgery. Tohoku J Exp Med. 2009;217:109–115. 
14.  Lawrence V, Hazuda H, Cornell J, et al. Functional independence after major 
abdominal surgery in the elderly. J Am Coll Surg. 2004;199:762–772. 
15.  Carli F, Charlebois P, Stein B, et al. Randomized clinical trial of prehabilitation in 
colorectal surgery. Br J Surg. 2010;97:1187–1197. 
16.  Heger P, Probst P, Wiskemann J, et al. A Systematic Review and Meta-analysis of 
Physical Exercise Prehabilitation in Major Abdominal Surgery (PROSPERO 2017 
CRD42017080366). J Gastrointest Surg. . Epub ahead of print June 2019. DOI: 
10.1007/s11605-019-04287-w. 
17.  Jack S, West M, Grocott MPW. Perioperative exercise training in elderly subjects. 
Best Pract Res Clin Anaesthesiol. 2011;25:461–472. 
18.  Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise 
intervention in cancer patients undergoing chemotherapy: randomised controlled trial. 
BMJ. 2009;339:b3410–b3410. 
19.  Nakajima H, Yokoyama Y, Inoue T, et al. Clinical Benefit of Preoperative Exercise and 
Nutritional Therapy for Patients Undergoing Hepato-Pancreato-Biliary Surgeries for 
Malignancy. Ann Surg Oncol. 2019;26:264–272. 
20.  Mazzola M, Bertoglio C, Boniardi M, et al. Frailty in major oncologic surgery of upper 
gastrointestinal tract: How to improve postoperative outcomes. Eur J Surg Oncol. 
2017;43:1566–1571. 
21.  Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo Classification of 
Surgical Complications. Ann Surg. 2009;250:187–196. 
22.  Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications. Ann 
 21 
Surg. 2004;240:205–213. 
23.  Bousquet-Dion G, Awasthi R, Loiselle SÈ, et al. Evaluation of supervised multimodal 
prehabilitation programme in cancer patients undergoing colorectal resection: a 
randomized control trial. Acta Oncol (Madr). 2018;57:849–859. 
24.  Timmons JA, Knudsen S, Rankinen T, et al. Using molecular classification to predict 
gains in maximal aerobic capacity following endurance exercise training in humans. J 
Appl Physiol. 2010;108:1487–1496. 
25.  Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and 
treatment in symptomatic cancer associated with poorer outcomes? Systematic 
review. Br J Cancer. 2015;112:S92–S107. 
26.  Schwegler I, von Holzen A, Gutzwiller J-P, et al. Nutritional risk is a clinical predictor 
of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 
2009;97:92–97. 
27.  Weimann A. Influence of nutritional status on postoperative outcome in patients with 
colorectal cancer – the emerging role of the microbiome. Innov Surg Sci. 2018;3:55. 
28.  Torres Flores F, Carretero Marin C, Fernández Peña JI, et al. Preoperative nutritional 
status of colorectal cancer patients is related with surgical outcomes. Clin Nutr. 
2018;37:S159–S160. 
29.  Cavagnari MAV, Silva TD, Pereira MAH, et al. Impact of genetic mutations and 
nutritional status on the survival of patients with colorectal cancer. BMC Cancer. 
2019;19:644. 
30.  MacFie J, Woodcock N., Palmer M., et al. Oral dietary supplements in pre- and 
postoperative surgical patients: a prospective and randomized clinical trial. Nutrition. 
2000;16:723–728. 
31.  Smedley F, Bowling T, James M, et al. Randomized clinical trial of the effects of 
 22 
preoperative and postoperative oral nutritional supplements on clinical course and 
cost of care. Br J Surg. 2004;91:983–990. 
32.  Manásek V, Bezdek K, Foltys A, et al. Vliv nutricní podpory s vysokým obsahem 
bílkovin na výsledky lécby a náklady u pacientu s kolorektálním karcinomem. TT  - 
The Impact of High Protein Nutritional Support on Clinical Outcomes and Treatment 
Costs of Patients with Colorectal Cancer. Klin Onkol. 2016;29:351–357. 
33.  Barberan-Garcia A, Ubré M, Roca J, et al. Personalised Prehabilitation in High-risk 
Patients Undergoing Elective Major Abdominal Surgery : A Randomized Blinded 
Controlled Trial. Ann Surg. 2018;267:50–56. 
34.  Chia CLK, Mantoo SK, Tan KY. “Start to finish trans-institutional transdisciplinary 
care”: A novel approach improves colorectal surgical results in frail elderly patients. 
Color Dis. 2016;18:O43–O50. 
35.  Meade L, Bearne L, Sweeney L, et al. Behaviour change techniques associated with 
adherence to prescribed exercise in patients with persistent musculoskeletal pain: 
Systematic review. Br J Health Psychol. 2018;24:10–30. 
36.  Scholz U, Nagy G, Göhner W, et al. Changes in self-regulatory cognitions as 
predictors of changes in smoking and nutrition behaviour. Psychol Health. 
2009;24:545–561. 
37.  Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review 
and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 
2015;350:g7647. 
38.  Dall’Ago P, Chiappa GRS, Guths H, et al. Inspiratory Muscle Training in Patients With 
Heart Failure and Inspiratory Muscle Weakness. J Am Coll Cardiol. 2006;47:757–763. 
39.  de Morton NA. The PEDro scale is a valid measure of the methodological quality of 
clinical trials: a demographic study. Aust J Physiother. 2009;55:129–133. 
 23 
40.  Duval S, Tweedie R. Trim and Fill: A Simple Funnel-Plot-Based Method of Testing 
and Adjusting for Publication Bias in Meta-Analysis. Biometrics. 2000;56:455–463. 
41.  Independent Cancer Taskforce. ACHIEVING WORLD-CLASS CANCER 
OUTCOMES. NHS Engl. 
42.  Kervio G, Carre F, Ville NS. Reliability and Intensity of the Six-Minute Walk Test in 
Healthy Elderly Subjects. Med Sci Sport Exerc. 2003;35:169–174. 
43.  Janssen TL, Steyerberg EW, Langenberg JCM, et al. Multimodal prehabilitation to 
reduce the incidence of delirium and other adverse events in elderly patients 
undergoing elective major abdominal surgery: An uncontrolled before-and-after study. 
PLoS One. 2019;14:1–16. 
44.  Kitahata Y, Hirono S, Kawai M, et al. Intensive perioperative rehabilitation improves 
surgical outcomes after pancreaticoduodenectomy. Langenbeck’s Arch Surg. 
2018;403:711–718. 
45.  Minnella EM, Awasthi R, Loiselle SE, et al. Effect of Exercise and Nutrition 
Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A 
Randomized Clinical Trial. JAMA Surg. 2018;153:1081–1089. 
46.  Gillis C, Loiselle SE, Fiore JF, et al. Prehabilitation with Whey Protein 
Supplementation on Perioperative Functional Exercise Capacity in Patients 
Undergoing Colorectal Resection for Cancer: A Pilot Double-Blinded Randomized 
Placebo-Controlled Trial. J Acad Nutr Diet. 2016;116:802–812. 
47.  Gillis C, Li C, Lee L, et al. Prehabilitation versus Rehabilitation. Anesthesiology. 
2014;121:937–947. 
48.  Antonescu I, Scott S, Tran TT, et al. Measuring postoperative recovery: What are 
clinically meaningful differences? Surgery. 2014;156:319–327. 
49.  Minnella EM, Bousquet-Dion G, Awasthi R, et al. Multimodal prehabilitation improves 
 24 
functional capacity before and after colorectal surgery for cancer: a five-year research 
experience. Acta Oncol (Madr). 2017;56:295–300. 
50.  Dalton SO, Bidstrup PE, Johansen C. Rehabilitation of cancer patients: Needed, but 
how? Acta Oncol (Madr). 2011;50:163–166. 
51.  Klika RJ, Golik KS, Drum SN, et al. Comparison of physiological response to 
cardiopulmonary exercise testing among cancer survivors and healthy controls. Eur J 
Appl Physiol. 2011;111:1167–1176. 
52.  Bouchard C, Rankinen T. Individual differences in response to regular physical 
activity. Med Sci Sports Exerc. 2001;33:S446–S451. 
53.  Courneya K, Segal RJ, Mckenzie DC, et al. Effects of Exercise during Adjuvant 
Chemotherapy on Breast Cancer Outcomes. Med Sci Sport Exerc. 2014;46:1744–
1751. 
54.  West MA, Astin R, Moyses HE, et al. Exercise prehabilitation may lead to augmented 
tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal 
cancer. Acta Oncol (Madr). 2019;58:588–595. 
55.  Junejo MA, Siriwardena AK, Parker MJ. Peripheral oxygen extraction in patients with 
malignant obstructive jaundice. Anaesthesia. 2014;69:32–36. 
56.  Ausania F, Senra P, Meléndez R, et al. Prehabilitation in patients undergoing 
pancreaticoduodenectomy: a randomized controlled trial. Rev Esp Enferm Dig. 
2019;111:603–608. 
57.  Bi L, Triadafilopoulos G. Exercise and gastrointestinal function and disease: an 
evidence-based review of risks and benefits. Clin Gastroenterol Hepatol. 2003;1:345–
355. 
58.  Kang CY, Chaudhry OO, Halabi WJ, et al. Outcomes of laparoscopic colorectal 
surgery: data from the Nationwide Inpatient Sample 2009. Am J Surg. 2012;204:952–
 25 
957. 
59.  Feldman LS, Kaneva P, Demyttenaere S, et al. Validation of a physical activity 
questionnaire (CHAMPS) as an indicator of postoperative recovery after laparoscopic 
cholecystectomy. Surgery. 2009;146:31–39. 
60.  Walker E, Hernandez A V, Kattan MW. Meta-analysis: Its strengths and limitations. 
Cleve Clin J Med.;75. 
61.  Simon R. Meta-analysis of Clinical Trials: Opportunities and Limitations. In: Meta-
Analysis in Medicine and Health Policy. New York: Marcel Dekker; 2000:305–319. 
62.  Grass F, Bertrand PC, Schäfer M, et al. Compliance with preoperative oral nutritional 
supplements in patients at nutritional risk─only a question of will? Eur J Clin Nutr. 
2015;69:525–529. 
63.  Albouaini K, Egred M, Alahmar A, et al. Cardiopulmonary exercise testing and its 













Figure legends and table titles 
Fig 1. PRISMA flow diagram of studies selected for systematic review 
 
Fig. 2 (a) Forest plot comparing the effects of prehabilitation on hospital length of stay. A 
negative value represents a shorter length of hospital stay in prehabilitation groups compared 
to standard care (b) Funnel plot of studies evaluating the effect of prehabilitation on hospital 
length of stay. 
 
Fig. 3 (a) Forest plot comparing the effects of prehabilitation on functional capacity as 
measured by the 6-minute walk test. A positive value represents a greater distance covered 
in prehabilitation groups compared to standard care (b) Funnel plot of studies evaluating the 
effect of prehabilitation on functional capacity 
 
Fig. 4 (a) The effects of prehabilitation on Clavien-Dindo ≥ III post-operative complications. A 
negative value represents a lower risk in prehabilitation groups compared to standard care (b) 
Funnel plot of studies evaluating the effect of prehabilitation on post-operative complications 
 
Fig. 5 (a) The effects of prehabilitation on mortality rates. (b) Funnel plot of studies evaluating 
the effect of prehabilitation on mortality rates.  
 
Table S1 Itemised PEDro scoring of all included studies 
 
Table S2 Characteristics of included studies  
  
